Follow
Naimi Johansson
Title
Cited by
Cited by
Year
Regional variation in health care utilization in Sweden–the importance of demand-side factors
N Johansson, N Jakobsson, M Svensson
BMC health services research 18, 1-9, 2018
382018
Effects of primary care cost-sharing among young adults: varying impact across income groups and gender
N Johansson, N Jakobsson, M Svensson
The European Journal of Health Economics 20, 1271-1280, 2019
232019
Reductions in out-of-pocket prices and forward-looking moral hazard in health care demand
N Johansson, SC de New, JS Kunz, D Petrie, M Svensson
Journal of health economics 87, 102710, 2023
82023
Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?
G Chauca Strand, N Johansson, N Jakobsson, C Bonander, M Svensson
Clinical drug investigation 43 (8), 621-633, 2023
62023
Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
GC Strand, C Bonander, N Jakobsson, N Johansson, M Svensson
ESMO open 7 (5), 100569, 2022
52022
Regional variation in prescription drug spending: Evidence from regional migrants in Sweden
N Johansson, M Svensson
Health Economics 31 (9), 1862-1877, 2022
42022
Vad kan förklara regionala skillnader i svensk hälso-och sjukvård
N Johansson
Rapport från SNS Analys, 2021
22021
Lifetime healthcare expenditures across socioeconomic groups in Sweden
S Fledsberg, M Svensson, N Johansson
European Journal of Public Health 33 (6), 994-1000, 2023
12023
Reproduction and replication analyses of Andersson (2019): A replication report from the Toronto Replication Games
C Bonander, N Jakobsson, N Johansson
I4R Discussion Paper Series, 2023
12023
Price sensitivity and regional variation in health care
N Johansson
12021
Place or patient as the driver of regional variation in healthcare spending–Discrepancies by category of care
N Johansson, N Jakobsson, M Svensson
Social Science & Medicine, 116571, 2024
2024
PCR221 Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data
M Svensson, GC Strand, C Bonander, N Johansson, N Jakobsson
Value in Health 26 (6), S353, 2023
2023
Healthcare cost consequences of changing diagnostic criteria for gestational diabetes mellitus (CDC4G) in Sweden: Alongside a stepped wedge cluster randomised trial
M de Brun, N Johansson, D Simmons, S Montgomery, K Berntorp, ...
2023
What explains regional differences in Swedish healthcare? Naimi Johansson
N Johansson
The system can't perform the operation now. Try again later.
Articles 1–14